CDC recommends Pfizer booster for kids 12 and up
The Centers for Disease Control and Prevention on Wednesday recommended that youths age 12 to 17 receive the Pfizer-BioNTech coronavirus vaccine booster.
"It is critical that we protect our children and teens from COVID-19 infection and the complications of severe disease," CDC Director Dr. Rochelle Walensky said. "I encourage all parents to keep their children up to date with CDC's COVID-19 vaccine recommendations." There are 16.7 million adolescents in the United States, and about half are fully vaccinated, The Washington Post reports.
The highly contagious Omicron variant is fueling a surge in COVID-19 cases across the U.S., and the country's seven-day case average hit 580,000 on Wednesday. Walensky said that data shows boosters "help broaden and strengthen protection against Omicron and other variants" in both children and adults. The number of children hospitalized with COVID-19, while still relatively low, is now higher than the previous record set last summer during the Delta surge, the Post reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia is night editor for TheWeek.com. Her writing and reporting has appeared in Entertainment Weekly and EW.com, The New York Times, The Book of Jezebel, and other publications. A Southern California native, Catherine is a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
'A financial windfall for Iranian terrorism'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Orangutan heals cut with medicinal plant
Speed Read A Sumatran orangutan in Indonesia has been self-medicating to heal a wound on his cheek
By Peter Weber, The Week US Published
-
Turkey halts trade with Israel in latest Gaza rift
Speed Read The country plans to join South Africa's genocide case against Israel
By Peter Weber, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published
-
Covid-19: what to know about UK's new Juno and Pirola variants
in depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
By Arion McNicoll, The Week UK Published
-
Long-term respiratory illness is here to stay
The Explainer Covid is not the only disease with a long version
By Devika Rao, The Week US Published